Ocrevus antibody for the treatment of Relapsing-Remitting Multiple Sclerosis (RMS). Patient taking partin the clinical trial shares that she's feeling great again with the ocrelizumab infusion.
A new research reveals a cellular mechanism that is responsible for the occurrence of multiple sclerosis. This breakthrough can open new opportunities in finding a new treatment for multiple sclerosis.
Scientists have discovered the key cells, significant in brain repair and could potentially revolutionize the treatment of neurological disorders such as multiple sclerosis.